Datavant × Aetion
Health data company Datavant acquired Aetion, a specialist in real-world evidence (RWE), to create an end-to-end platform for analyzing disparate health data sources. [35] The deal combines Datavant's data connectivity platform with Aetion's analytics software, which is used to answer research questions about the clinical impact of therapies. [35] One source reported the transaction as a leveraged buyout with an estimated value of $400 million, announced on July 11, 2025, while another reported the deal announcement on May 16, 2025. [35, 41]
The asset
Acquisition of Aetion, a healthcare analytics company with a platform for generating real-world evidence (RWE) from clinical and claims data to assess the safety, effectiveness, and value of medical treatments. [35, 41]
- 300 data partners in combined ecosystem
The record
- Seller status
- Going concern
- Sector
- Real-world evidence and healthcare analytics
- Modalities
- real-world_data, clinical_data, claims_data
- Jurisdiction
- US
- Personal data
- Datavant's core business involves managing and sharing anonymised or de-identified patient data for life sciences and healthcare partners. [35]
What it means if you hold data
This acquisition represents a significant consolidation in the real-world evidence market, creating a powerful, integrated platform for life sciences companies. The deal highlights the increasing importance of combining data connectivity (accessing siloed datasets) with sophisticated analytics to generate regulatory-grade evidence for therapies. [35]